Ratings AlzChem Group AG

Equities

ACT

DE000A2YNT30

Market Closed - Xetra Other stock markets 11:36:26 2024-04-25 am EDT			After market 02:41:02 pm
44.9 ^EUR	-5.07%		45.1	+0.45%

Mar. 15	German arms industry receives EU millions for projects	DP
Mar. 01	Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

With regards to fundamentals, the enterprise value to sales ratio is at 0.92 for the current period. Therefore, the company is undervalued.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the past twelve months, EPS forecast has been revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
ALZCHEM GROUP AG	+72.69%	514M	C+
SHIN-ETSU CHEMICAL CO., LTD.	+6.61%	83.41B	B
BASF SE	+4.53%	48.95B	A-
DUPONT DE NEMOURS, INC.	-4.55%	30.92B	C
PIDILITE INDUSTRIES LIMITED	+7.53%	18.01B	B
BRENNTAG SE	-9.08%	11.74B	B
EASTMAN CHEMICAL COMPANY	+6.66%	11.33B	A-
SYENSQO SA/NV	-9.19%	9.67B	-
ASAHI KASEI CORPORATION	+2.79%	9.6B	A-
SRF LIMITED	+6.41%	9.3B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes